Drug Compound Kills Breast Cancer Stem Cells, Massachusetts Institute of Technology (MIT) Study

CHICAGO (Reuters) - U.S. researchers have discovered a compound that can kill breast cancer stem cells, a kind of master cancer cell that resists conventional treatment and may explain why many cancers grow back, they reported on Thursday.

MORE ON THIS TOPIC